Search Results - "Levy, Miriam T"

Refine Results
  1. 1

    Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus by Greenup, Astrid-Jane, Tan, Pok Kern, Nguyen, Vi, Glass, Anne, Davison, Scott, Chatterjee, Ushmi, Holdaway, Susan, Samarasinghe, Dev, Jackson, Kathy, Locarnini, Stephen A, Levy, Miriam T

    Published in Journal of hepatology (01-09-2014)
    “…Background & Aims Perinatal transmission of hepatitis B virus still occurs despite immunoprophylaxis in approximately 9% of children from highly viraemic…”
    Get full text
    Journal Article
  2. 2

    Australian recommendations for the management of hepatocellular carcinoma: a consensus statement by Lubel, John S, Roberts, Stuart K, Strasser, Simone I, Thompson, Alexander J, Philip, Jennifer, Goodwin, Mark, Clarke, Stephen, Crawford, Darrell HG, Levy, Miriam T, Shackel, Nick

    Published in Medical journal of Australia (01-06-2021)
    “…Introduction Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths both globally and in Australia. Surveillance for HCC in at‐risk populations…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Perinatal transmission of hepatitis B virus: an Australian experience by Wiseman, Elke, Fraser, Melissa A, Holden, Sally, Glass, Anne, Kidson, Bronwynne L, Heron, Leon G, Maley, Michael W, Ayres, Anna, Locarnini, Stephen A, Levy, Miriam T

    Published in Medical journal of Australia (04-05-2009)
    “…Objective: To determine the rate of perinatal hepatitis B virus (HBV) transmission in an Australian setting and to identify maternal virological factors…”
    Get full text
    Journal Article
  4. 4

    Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia by Chan, Patrick P Y, Levy, Miriam T, Shackel, Nicholas, Davison, Scott A, Prakoso, Emilia

    “…Despite efficacy in HCV eradication, direct-acting antiviral (DAA) therapy has raised controversies around their impact on hepatocellular carcinoma (HCC)…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection—Authors' reply by Levy, Miriam T., Kashuba, Angela, Gane, Edward

    Published in Alimentary pharmacology & therapeutics (01-08-2022)
    “…LINKED CONTENT This article is linked to Kayes et al papers. To view these articles, visit https://doi.org/10.1111/apt.17040…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Viral hepatitis and pregnancy by Terrault, Norah A., Levy, Miriam T., Cheung, Ka Wang, Jourdain, Gonzague

    “…The management of viral hepatitis in the setting of pregnancy requires special consideration. There are five liver-specific viruses (hepatitis A, B, C, D, E),…”
    Get full text
    Journal Article
  10. 10

    Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate by Sohara, Naondo, Znoyko, Iya, Levy, Miriam T, Trojanowska, Maria, Reuben, Adrian

    Published in Journal of hepatology (01-08-2002)
    “…Background: Liver injury transforms hepatic stellate cells into myofibroblast (MFB)-like cells. With recovery from injury, MFBs undergo apoptosis, but it is…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection by Holt, Stephen G, Gracey, David M, Levy, Miriam T, Mudge, David W, Irish, Ashley B, Walker, Rowan G, Baer, Richard, Sevastos, Jacob, Abbas, Riaz, Boyd, Mark A

    Published in AIDS research and therapy (10-11-2014)
    “…A number of antiviral agents used against Human Immunodeficiency Virus (HIV) infection and hepatitis B virus (HBV) mono or co-infection have been associated…”
    Get full text
    Journal Article
  14. 14

    Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection by Kayes, Tahrima, Crane, Harry, Symonds, Allison, Dumond, Julie, Cottrell, Mackenzie, Di Girolamo, Julia, Manandhar, Sicha, Lim, Tien Huey, Gane, Edward, Kashuba, Angela, Levy, Miriam T.

    Published in Alimentary pharmacology & therapeutics (01-08-2022)
    “…Summary Background Antenatal antiviral therapy (AVT) is effective in preventing mother‐to‐child transmission (MTCT) in chronic hepatitis B (CHB); tenofovir…”
    Get full text
    Journal Article
  15. 15

    All‐cause hepatocellular carcinoma survival in the era of direct‐acting antiviral therapy by Lockart, Ian, Hajarizadeh, Behzad, Buckley, Niamh, Davison, Scott, Prakoso, Emilia, Levy, Miriam T, George, Jacob, Dore, Gregory J, Danta, Mark

    Published in Journal of gastroenterology and hepatology (01-12-2021)
    “…Background and Aim Hepatitis C virus (HCV) cure with direct‐acting antiviral (DAA) therapy improves survival in patients with HCV‐related hepatocellular…”
    Get full text
    Journal Article
  16. 16

    Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival by Lockart, Ian, Hajarizadeh, Behzad, Alavi, Maryam, Davison, Scott, Prakoso, Emilia, Levy, Miriam T., George, Jacob, Dore, Gregory J., Danta, Mark

    Published in Journal of viral hepatitis (01-05-2021)
    “…The impact of hepatitis C virus (HCV) cure on survival in patients with HCV‐related hepatocellular carcinoma (HCC) has been examined, although many studies…”
    Get full text
    Journal Article
  17. 17

    Editorial: the emergence of non‐hypervascular hypointense nodules on Gd‐EOB‐DTPA‐enhanced MRI in patients with chronic hepatitis C by Crane, Harry G., Davison, Scott A., Levy, Miriam T.

    Published in Alimentary pharmacology & therapeutics (01-01-2020)
    “…LINKED CONTENTThis article is linked to Toyoda et al papers. To view these articles, visit https://doi.org/10.1111/apt.15490 and…”
    Get full text
    Journal Article
  18. 18

    Hepatitis A to E: what's new? by Mohsen, Waled, Levy, Miriam T.

    Published in Internal medicine journal (01-04-2017)
    “…Viral hepatitis contributes to significant morbidity and mortality worldwide. While acute infection may be self‐limiting, unrecognised chronic infection and…”
    Get full text
    Journal Article
  19. 19

    Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore by Thilakanathan, Cynthuja, Kayes, Tahrima, Di Girolamo, Julia, Nguyen, Vi, Glass, Anne, Manandhar, Sicha, Lawler, Joseph, Meredith, Chris, Maley, Michael, Lloyd, Andrew, Levy, Miriam T.

    Published in Liver international (01-01-2023)
    “…Background and Aims Achieving Hepatitis B e antigen seroconversion (HBeAg SC) at an earlier age confers a better prognosis. We examined baseline and…”
    Get full text
    Journal Article
  20. 20

    Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia by Yeoh, Yuen Kang Joseph, Dore, Gregory J., Lockart, Ian, Danta, Mark, Flynn, Ciara, Blackmore, Conner, Levy, Miriam T., George, Jacob, Alavi, Maryam, Hajarizadeh, Behzad

    Published in Internal medicine journal (01-04-2024)
    “…Background Viral hepatitis, alcohol‐related liver disease (ARLD) and nonalcoholic fatty liver disease (NAFLD) are the main risk factors for hepatocellular…”
    Get full text
    Journal Article